Caffeine and cognitive performance: Persistent methodological challenges in caffeine research

被引:26
作者
James, Jack E. [1 ,2 ]
机构
[1] Reykjavik Univ, IS-101 Reykjavik, Iceland
[2] Natl Univ Ireland, Galway, Ireland
关键词
Caffeine; Cognitive performance; Caffeine-naive; Placebo control; Methodological challenges; HABITUAL NON-CONSUMERS; DIETARY CAFFEINE; PLASMA-CONCENTRATIONS; MOOD; WITHDRAWAL; PSYCHOSTIMULANT; CONSUMPTION; VALIDATION; BEVERAGES; ATTENTION;
D O I
10.1016/j.pbb.2014.05.019
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Human cognitive performance is widely perceived to be enhanced by caffeine at usual dietary doses. However, the evidence for and against this belief continues to be vigorously contested. Controversy has centred on caffeine withdrawal and withdrawal reversal as potential sources of experimental confounding. In response, some researchers have enlisted "caffeine-naive" experimental participants (persons alleged to consume little or no caffeine) assuming that they are not subject to withdrawal. This mini-review examines relevant research to illustrate general methodological challenges that have been the cause of enduring confusion in caffeine research. At issue are the processes of caffeine withdrawal and withdrawal reversal, the definition of caffeine-naive, the population representativeness of participants deemed to be caffeine-naive, and confounding due to caffeine tolerance. Attention to these processes is necessary if premature conclusions are to be avoided, and if caffeine's complex effects and the mechanisms responsible for those effects are to be illuminated. Strategies are described for future caffeine research aimed at minimising confounding from withdrawal and withdrawal reversal. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 44 条
  • [1] Association between A2a receptor gene polymorphisms and caffeine-induced anxiety
    Alsene, K
    Deckert, J
    Sand, P
    de Wit, H
    [J]. NEUROPSYCHOPHARMACOLOGY, 2003, 28 (09) : 1694 - 1702
  • [2] Coffee and cardiovascular disease:: In vitro, cellular, animal, and human studies
    Bonita, Jennifer Stella
    Mandarano, Michael
    Shuta, Donna
    Vinson, Joe
    [J]. PHARMACOLOGICAL RESEARCH, 2007, 55 (03) : 187 - 198
  • [3] Borota D, 2014, NAT NEUROSCI
  • [4] BRAZIER JL, 1981, SEMIN PERINATOL, V5, P315
  • [5] Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users
    Childs, E
    de Wit, H
    [J]. PSYCHOPHARMACOLOGY, 2006, 185 (04) : 514 - 523
  • [6] Effects of caffeine in non-withdrawn volunteers
    Christopher, G
    Sutherland, D
    Smith, A
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (01) : 47 - 53
  • [7] Occurrence and concentration of caffeine in Oregon coastal waters
    del Rey, Zoe Rodriguez
    Granek, Elise F.
    Sylvester, Steve
    [J]. MARINE POLLUTION BULLETIN, 2012, 64 (07) : 1417 - 1424
  • [8] Caffeine as an attention enhancer: reviewing existing assumptions
    Einother, Suzanne J. L.
    Giesbrecht, Timo
    [J]. PSYCHOPHARMACOLOGY, 2013, 225 (02) : 251 - 274
  • [9] An update on the mechanisms of the psychostimulant effects of caffeine
    Ferre, Sergi
    [J]. JOURNAL OF NEUROCHEMISTRY, 2008, 105 (04) : 1067 - 1079
  • [10] GOLDSTEIN A, 1969, CLIN PHARMACOL THER, V10, P489